Several studies pointed out that NGF promotes the survival of cholinergic neurons in Alzheimer’s disease (AD) [4], although its use in the therapy of AD is limited by its poor metabolic stability and low blood-brain barrier permeability [5]. This evidence concerns the gene NGF and early-onset autosomal dominant Alzheimer disease.